News about Hazardous and Toxic Substances, including commentary and archival articles published in The New York Times.

C. difficile Toxin A & B Detection by EIA For more than 20 years the detection of toxin A/B from fecal samples by immunoenzymatic methods has been the cornerstone of laboratory CDI diagnosis ...

What are the keys to successful diagnosis and treatment of C. diff?

The frequency and severity of human infections associated with Corynebacterium ulcerans appear to be increasing in different countries. Here, we describe the first C. ulcerans strain producing a ...

Under the agreement, GENCURIX will develop in vitro diagnostic (IVD) kits utilizing QIAGEN’s digital PCR system, QIAcuityDx Four, while QIAGEN will hold exclusive global distribution rights. The ...

Through this collaboration, GENCURIX will integrate its proprietary molecular diagnostic technologies and biomarker-driven cancer detection capabilities with QIAGEN’s digital PCR and software ...

SEOUL, SOUTH KOREA, June 19, 2025 / EINPresswire.com / -- GENCURIX, Inc., a leading molecular diagnostics company specializing in oncology, today announced that it has signed a global development and ...

Researchers claim they have discovered an airborne toxin in the United States for the first time ever, and we don't know its lasting effects.

The researchers first noted a drawing in a paper published 94 years ago with a description that suggested the feather-legged lace weaver spider regurgitated its toxin and used it to wet its silk ...